Search - tctmd.com

Displaying 541 - 560 of 3096

Sort: Relevancy | Date

Presentation NY Valves 2024

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Presenter: Neel Butala

June 05, 2024

Presentation NY Valves 2024

A Novel AI-Powered Non-Invasive Screening Device for Aortic Stenosis (Clearsight)

Presenter: Joseph Kassab

June 05, 2024

Presentation NY Valves 2024

Lifetime Management of Transcatheter Tricuspid Valve Replacement: Patient and Device Considerations

Presenter: Gabriel Sayer

June 05, 2024

Presentation NY Valves 2024

Case Presentation: M-TEER in Commissural Disease: Device Selection and Procedural Considerations

Presenter: Sam Dawkins

June 05, 2024

Presentation NY Valves 2024

Case Presentation: M-TEER in a Small Left Atrium: Device Selection and Procedural Considerations

Presenter: Tom Cahill

June 05, 2024

Presentation NY Valves 2024

Case Presentation: Unraveling Post-M-TEER Gradients: Evaluating Risk of Mitral Stenosis

Presenter: Masahiko Asami

June 05, 2024

Presentation NY Valves 2024

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Presenter: Amar Krishnaswamy

June 05, 2024

Presentation EuroPCR 2024

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Presenter: Patrick Serruys

May 15, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

Presentation THT 2024

Regulatory Matters Related to Monitoring Devices

Presenter: Liviu Klein

March 06, 2024

Presentation THT 2024

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

Presenter: William T. Abraham

March 06, 2024

Presentation THT 2024

Temperature Controlled Devices

Presenter: Andreas Zuckermann

March 06, 2024

Presentation THT 2024

Inclusion Criteria and Endpoints for Trials of Devices to Treat ADHF

Presenter: Maria Rosa Costanzo

March 06, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

Acute and Chronic Outcomes in Early Feasibility Evaluation of Device-Based Thoracic Duct Decompression in Hospitalized Acute Decompensated Heart Failure Patients

Presenter: William T. Abraham

March 06, 2024

Presentation THT 2024

CRT/ICD in LVAD Patients

Presenter: Gabriel Sayer

March 05, 2024

Presentation THT 2024

Impact of Conduction System Pacing on LV Function (PV Loops)

Presenter: Petr Neuzil

March 05, 2024

Presentation THT 2024

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

Presenter: David M. Kaye

March 05, 2024

Presentation THT 2024

Conduction System Pacing vs CRT in HF

Presenter: Sammy Khatib

March 05, 2024

Presentation THT 2024

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

Presenter: Kevin Makati

March 05, 2024

Advertisement

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

A Novel AI-Powered Non-Invasive Screening Device for Aortic Stenosis (Clearsight)

Lifetime Management of Transcatheter Tricuspid Valve Replacement: Patient and Device Considerations

Case Presentation: M-TEER in Commissural Disease: Device Selection and Procedural Considerations

Case Presentation: M-TEER in a Small Left Atrium: Device Selection and Procedural Considerations

Case Presentation: Unraveling Post-M-TEER Gradients: Evaluating Risk of Mitral Stenosis

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Regulatory Matters Related to Monitoring Devices

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

Temperature Controlled Devices

Inclusion Criteria and Endpoints for Trials of Devices to Treat ADHF

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Acute and Chronic Outcomes in Early Feasibility Evaluation of Device-Based Thoracic Duct Decompression in Hospitalized Acute Decompensated Heart Failure Patients

CRT/ICD in LVAD Patients

Impact of Conduction System Pacing on LV Function (PV Loops)

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

Conduction System Pacing vs CRT in HF

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content